Patients may require life-long monitoring and a collaborative engagement with subspecialists to keep well in the long -term,” ...

Ronan J. Kelly, MD, MBA, discusses the targeted therapy options that have become available for patients with gastric, esophageal, and gastroesophageal junction cancers.

Recent long-term data on pembrolizumab and nivolumab has reaffirmed the benefits of anti-PD-1 therapies in managing residual melanoma. However, Funck-Brentano cautioned, “Most patients do not ...

Health systems are facing hurdles to implementing new and effective metastatic urothelial carcinoma (mUC) therapies into ...

American Society of Clinical Oncology Genitourinary (ASCO GU) cancers symposium held in San Francisco, CA between February 13 ...

A world-first trial in Adelaide is taking blood from cancer patients, purifying it through a new hi-tech device then pumping it back, in the hope it can improve the body’s own natural ability to fight ...